News
News
Exactech to Present at the 2009 Noble Financial Equity Conference on June 8
GAINESVILLE, Fla. -- June 1, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will present at the Fifth Annual Noble Financial Equity Conference in Hollywood, Florida. The two-day investor conference will showcase 140 small cap public companies.
Exactech Q1 Revenue Increases 9% to $43.3 Million
GAINESVILLE, Fla. -- April 29, 2009 -- Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $43.3 million for the first quarter of 2009, a 9% increase over $39.8 million in the first quarter of 2008. Net income was $2.5 million, or $0.19 per diluted share, compared to $2.8 million, or $0.23 per diluted share, in the same quarter a year ago. Net income for the quarter, excluding pre-tax legal expenses and costs of $1.4 million related to the ongoing Department of Justice (DOJ) inquiry, was $3.3 million or $0.26 EPS.
Exactech Schedules First Quarter 2009 Earnings Release and Conference Call
GAINESVILLE, Fla. -- April 23, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its first quarter financial results on Wednesday, April 29, 2009 after regular trading hours end. A copy of the earnings release will be available at http://www.hawkassociates.com.
Pro Golfer Peter Jacobsen Endorses Exactech Knee Following Successful Knee Replacement
GAINESVILLE, Fla. -- March 12, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the company has partnered with professional golfer Peter Jacobsen to tell the story of his successful knee replacement with Exactech’s Optetrak® total knee system in 2008.
Exactech Receives Patent for Rotating Bearing Knee, Optetrak RBK System
GAINESVILLE, Fla. -- February 24, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that is has been issued U.S. Patent 7,422,605,B2 for its rotating bearing knee prosthesis, Optetrak® RBK™.
Exactech to Present Growth Strategies at Canaccord Adams Musculoskeletal Conference in Conjunction With AAOS Orthopaedic Meeting
GAINESVILLE, Fla. -- February 23, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced its schedule of future events.
Exactech Extends Knee Development License with Hospital for Special Surgery
GAINESVILLE, Fla. -- February 23, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that it has extended its relationship with Hospital for Special Surgery, New York, NY, to further advance implant designs for total knee replacement surgery. Exactech plans to introduce a new knee implant as an evolution of its flagship Optetrak® brand, as a result of this continued collaboration. Limited release of the new knee is expected in the second half of 2009.
Exactech 2008 Revenue Up 30% to $162M; Net Income Up 31% to $11.1M, EPS $0.87
GAINESVILLE, Fla. -- February 18, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that revenue for 2008 increased 30% to $161.7 million from $124.2 million in 2007. Diluted earnings per share for the year was $0.87 based on net income of $11.1 million. This compares with net income of $8.5 million or $0.72 diluted EPS a year ago. Net income for 2008 included pre-tax legal expenses and costs of $2.6 million related to the ongoing Department of Justice (DOJ) inquiry.
Exactech, Inc. Announces Year End Earnings and Conference Call
GAINESVILLE, Fla. -- Feb. 12, 2009 -- Exactech, Inc. (Nasdaq: EXAC,), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its fourth quarter and 2008 year-end earnings on Wednesday, February 18, 2009, after the market closes.
